629 studies found for:    "Hypertension, Pulmonary"
Show Display Options
Rank Status Study
21 Completed Safety and Efficacy of Terbogrel in Patients With Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Terbogrel low dose;   Drug: Terbogrel high dose;   Drug: Placebo
22 Completed Atorvastatin in Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Interventions: Drug: Atorvastatin;   Drug: Placebo
23 Completed Safety Follow-up Study of Inhaled Iloprost in Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Ventavis (Iloprost, BAYQ6256)
24 Not yet recruiting Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Riociguat for Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (ADEMPAS, BAY63-2521)
25 Terminated Study of the Efficacy and Safety of Tezosentan in Patients With Pre-operative Pulmonary Hypertension, Due to Left Heart Disease, Undergoing Open Heart Surgery
Conditions: Heart Diseases;   Hypertension, Pulmonary
Interventions: Drug: tezosentan;   Drug: placebo
26 Recruiting Targeting the Right Ventricle in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Interventions: Drug: Ranolazine;   Drug: Placebo
27 Recruiting A Case Control Study of the Prevalence of Pulmonary Hypertension in Patients With Myeloproliferative Diseases.
Conditions: Myeloproliferative Disease;   Pulmonary Hypertension
Intervention: Other: myeloproliferative disease
28 Unknown  The Role of Endothelin in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: BQ-123
29 Recruiting Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)
Condition: Idiopathic Interstitial Pneumonias / Hypertension,Pulmonary
Interventions: Drug: Adempas, Riociguat (BAY63-2521);   Device: Placebo
30 Unknown  Ambrisentan (Letairis) for Sarcoidosis Associated Pulmonary Hypertension
Conditions: Sarcoidosis;   Pulmonary Hypertension
Intervention: Drug: Ambrisentan
31 Completed Serotonin Transporter Inhibitor Escitalopram in Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention: Drug: escitalopram
32 Completed Phase IV Study of Chronic Infusional Epoprostenol for Severe Primary Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: epoprostenol
33 Completed An Open Multiple Dose Titration Study In Patients With Pulmonary Hypertension
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (Adempas, BAY63-2521)
34 Recruiting Treatment of Pulmonary Hypertension Associated COPD With Inhaled Treprostinil-1
Conditions: Pulmonary Hypertension;   COPD
Intervention: Drug: Inhaled Treprostinil Therapy
35 Recruiting Chronic Obstructive Pulmonary Disease and Pulmonary Hypertension: Prevalence and Quality of Life
Conditions: Hypertension, Pulmonary;   Pulmonary Disease, Chronic Obstructive
Intervention:
36 Withdrawn Inhaled Iloprost as an Adjunct to Inhaled Nitric Oxide in Pediatric Critical Care Patients
Conditions: Pulmonary Hypertension;   Neonatal Hypoxic Respiratory Failure;   Persistent Pulmonary Hypertension of Newborn;   Congenital Heart Defects;   Acute Respiratory Distress Syndrome
Interventions: Drug: Iloprost;   Drug: Placebo
37 Completed Interaction Study in Patients With Pulmonary Hypertension and Stable Treatment of Sildenafil 20 mg TID
Condition: Hypertension, Pulmonary
Intervention: Drug: Riociguat (BAY63-2521)
38 Available Riociguat in Patients With Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Hypertension, Pulmonary
Intervention: Drug: Adempas (Riociguat, BAY63-2521)
39 Terminated Inhaled Iloprost for the Treatment of Persistent Pulmonary Hypertension in the Term and Near Term Infants.
Condition: Pulmonary Hypertension
Intervention: Drug: Inhaled Iloprost
40 Completed
Has Results
Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)
Condition: Pulmonary Hypertension
Intervention: Drug: bosentan

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years